NuLife Peptides
Retatrutide
Finnrick tested 2 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from NuLife Peptides on 5 Mar 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
NuLife Peptides
Retatrutide
Tested 2 Samples
Last test 5 Mar 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from NuLife Peptides
Samples are tested in commercial labs
Tests Count
2
Scores
AVGMINMAX
Last
5 Mar 2026
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |